|
ASCO Direct GU: A multistakeholder blended-learning project to make global education local. |
| |
|
Honoraria - Advanced Accelerator Applications; Amgen; Bayer Schering Pharma; Bristol-Myers Squibb; Ferring; Janssen Oncology; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sotio; Tolmar |
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; Bayer Schering Pharma; Bristol-Myers Squibb; Ferring; Janssen Oncology; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sotio; Tolmar |
Speakers' Bureau - Janssen Oncology |
Travel, Accommodations, Expenses - Amgen Astellas BioPharma; Bayer Schering Pharma; Bristol-Myers Squibb; Ferring; Janssen Oncology; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Tolmar |
| |
|
|
Stock and Other Ownership Interests - Bayer |
| |
|
No Relationships to Disclose |
| |
|
Employment - Janssen Research & Development |
Stock and Other Ownership Interests - Janssen Research & Development |
Other Relationship - European Federation of Pharmaceutical Industries and Associations Medical Education Working Group; iPACME |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Ipsen; Janssen; Pfizer; Sanofi |
Speakers' Bureau - Astellas Pharma; Bayer; Ferring; Ipsen; Janssen; Pfizer; Sanofi |
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Ferring (Inst); Ipsen (Inst); Janssen (Inst) |
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ferring; Ipsen; Janssen; Pfizer; Sanofi |